Schedule 13G ownership disclosure

ALDER BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 014339105

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,712,078
Percent of class
11.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-19-002665
Form type
SC 13G/A
Filer
ALDER BIOPHARMACEUTICALS INC
CIK
CIK 1423824
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub